Executive Director, Global Commercial Lead, HCC

BeOne continues to grow at a rapid pace with challenging and exciting opportunities for experienced professionals. When considering candidates, we look for scientific and business professionals who are highly motivated, collaborative, and most importantly, share our passionate interest in fighting cancer.
General Description:

BeOne’s Solid Tumor organization has committed to advancing novel therapies across 3 core franchises: Breast/Gynecological, Gastrointestinal (GI), and Lung Cancers. Having advanced more than 20 clinical candidates in the past 3 years within these franchises, the company will present proof-of-concept data on 5 assets before end-2026. Within the GI franchise, BeOne presented at ASCO 2026 proof-of-concept data for our GPC3x41BB bispecific antibody in late line HCC patients. BeOne has now formed a Global Product Team (GPT) to execute registration-intent studies for this molecule, and will soon be forming a corresponding Global Brand Teams (GBT) to deliver successful commercial launches around the globe.

This highly visible role will serve as the Global Commercial Lead (GCL) for this asset with responsibility to drive launch preparations and readiness across global functions and affiliate partners. The person selected for this role will mobilize the first GBT for the GI franchise with team members representing different functions and markets. Together, the GBT will create the first global brand plan for this asset that confirms the opportunity size, defines the commercial strategies to realize the opportunity, and identifies and leads implementation of the tactical plans to achieve successful commercial launches around the globe.

The person selected for this role will need to be visionary and a recognized leader across the R&D and commercial interface. He / she will collaborate closely with cross-functional teams to ensure alignment with business objectives and market needs across various functional disciplines and BeOne Regions. This role requires a deep understanding of drug development and commercialization processes, strong leadership capabilities, and a proven track record in working cross-functionally to lead matrix teams across the entirety of product launch and LCM planning. The role reports to the Vice President, Global Commercial Strategy & Operations (GCSO), Solid Tumors.
Essential Functions of the Job:

-
Provide strategic leadership for a highly visible asset within our Solid Tumor pipeline, developing the global commercial strategies for first launch, helping to shape the lifecycle management plan, serving as the commercial voice at the Global Product Team (GPT), and representing the Brand across BeOne territories, with senior leadership, and with external stakeholders.

-
Lead the Global Brand Team (GBT) ensuring productive information exchange and best practice sharing between GPT, GBT, and regional / affiliate team members. Develop an aligned view of brand growth drivers and ensure progress to plan consistent with agreed business objectives.

-
Represent ONE commercial voice to Global Product Team (GPT), R&D, Tech Ops, Executive Leadership, and Solid Tumor Franchise Teams to drive organizational alignment and progress.

-
Lead key cross-functional processes including the Annual Brand Plan, the Annual Operating Plan (AOP), and the Long-Range Plan (LRP) processes.

-
Build, inspire, and develop talent within the global commercial team as BeOne resources the brand teams through launch preparations and commercialization.

-
Collaborate with cross-regional and cross-functional team members to shape brand strategies for multiple indications to form an integrated view of lifecycle management priorities.

-
Integrate major market input into global launch readiness plans and support the implementation / execution of global commercial strategies in local markets.

-
Ensure long-term growth by translating complex clinical evidence into a unified global narrative that drives market leaders